Reduced Fhit protein expression in nickel-transformed mouse cells and in nickel-induced murine sarcomas

被引:0
作者
Renata Kowara
Konstantin Salnikow
Bhalchandra A. Diwan
Robert M. Bare
Michael P. Waalkes
Kazimierz S. Kasprzak
机构
[1] National Cancer Institute at Frederick,Laboratory of Comparative Carcinogenesis
[2] New York University School of Medicine,Laboratory of Molecular Toxicology and Carcinogenesis, Department of Environmental Medicine
[3] Basic Research Program,undefined
[4] SAIC Frederick,undefined
[5] NIEHS,undefined
来源
Molecular and Cellular Biochemistry | 2004年 / 255卷
关键词
Fhit; nickel; carcinogenesis; murine sarcomas;
D O I
暂无
中图分类号
学科分类号
摘要
Nickel compounds are carcinogenic and induce malignant transformation of cultured cells. Since nickel has low mutagenic potential, it may act predominantly through epigenetic mechanisms, including down-regulation of tumor suppressor genes. FHIT is a tumor suppressor gene whose expression is frequently reduced or lost in tumors and pre-malignant lesions. Previously, we have shown that the phosphohydrolase activity of Fhit protein, associated with its tumor suppressor action, is inhibited by nickel [12]. In cells, such effect would assist in carcinogenesis. The latter could be further enhanced if nickel also lowered cellular levels of Fhit protein itself, e.g. by down-regulation of FHIT gene. To test this possibility, we determined Fhit protein and Fhit-mRNA levels in a nickel-transformed mouse cell line and in nickel-induced murine sarcomas. In B200 cells, derived by nickel treatment of BALB/c-3T3 cells and exhibiting a malignant phenotype, Fhit protein levels were 50% of those in the parental cells, while Fhit-mRNA expression remained unchanged. A decrease of up to > 90percnt; in Fhit protein levels was also observed in 22 local sarcomas (mostly fibrosarcomas) induced by i.m. injection of nickel subsulfide in C57BL/6 and MT+ (C57BL/6 overexpressing metallothionein) mice, as compared with normal muscles. Moreover, Fhit was absent in 3 out of 10 sarcomas from MT+ mice and in 1 of 12 sarcomas from C57BL/6 mice. The lack of Fhit protein coincided with the absence of the Fhit-mRNA transcript in these tumors. However, in the other tumors, the decreased Fhit levels were not always accompanied by reduced expression of Fhit-mRNA. Thus, the observed lowering of Fhit protein levels is mostly associated with changes in mRNA expression and protein translation or turnover rates, and rarely with a full silencing of the gene itself. Overall, the decline of Fhit in cells or tissues malignantly transformed by nickel may indicate possible involvement of this effect in the mechanisms of nickel carcinogenesis.
引用
收藏
页码:195 / 202
页数:7
相关论文
共 211 条
[1]  
Huebner K(1998)The role of the Annu Rev Genet 32 7-31
[2]  
Garrison PN(1999) locus in cancer J Clin Oncol 17 1618-1624
[3]  
Barnes LD(2000)Role of Cancer Res 60 2780-2785
[4]  
Croce CM(2002) in human cancer Cancer Res 62 3477-3484
[5]  
Croce C(1996)Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression Biochemistry 35 11529-11535
[6]  
Sozzi G(1997)FRA3B locus. Identification of unstable sequences within the common fragile site at 3p14.2: Implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors Proc Natl Acad Sci USA 94 13771-13776
[7]  
Huebner K(1999)Fhit, a putative tumor suppressor in humans, is a dinucleoside 5′,5‴-P J Biol Chem 274 24378-24382
[8]  
Werner NS(2000),P Biochem J 352 443-448
[9]  
Siprashvili Z(1999)-triphosphate hydrolase Proc Natl Acad Sci USA 96 8489-8492
[10]  
Fong LY(1999)Replacement of Fhit in cancer cells suppresses tumorigenicity Cancer Res 59 3333-3339